Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

BCL9-2 Antibody, FITC, Novus Biologicals™
SDP

Catalog No. NB291013 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB291013 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB291013 Supplier Novus Biologicals Supplier No. NBP171907F
Add to Cart
Add to Cart

Rabbit Polyclonal Antibody

BCL9-2 Polyclonal antibody specifically detects BCL9-2 in Human samples. It is validated for Western Blot, Immunoprecipitation

Specifications

Antigen BCL9-2
Applications Western Blot, Immunoprecipitation
Classification Polyclonal
Conjugate FITC
Dilution Western Blot, Immunoprecipitation
Formulation PBS
Gene Alias B-cell CLL/lymphoma 9-like, B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein, DLNB11BCL9-2, nuclear co-factor of beta-catenin signalling, Protein BCL9-2
Host Species Rabbit
Immunogen The immunogen for this product maps to a region between residue 525 and 575 of human B-Cell CLL/Lymphoma 9-Like using the numbering given in entry NP_872363.1 (GeneID 283149).
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cancer, Cell Cycle and Replication
Primary or Secondary Primary
Gene ID (Entrez) 283149
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.